DOCSLIB.ORG

Healon Project (1971-77)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Healon Project (1971-77) The Magic Molecule that has improved the lives of millions Börje Svensson Copyright The publisher will keep this document online on the Internet – or its possible replacement – for a considerable time from the date of publication barring exceptional circumstances. The online availability of the document implies permanent permission for anyone to read, to download, or to print out single copies for his/her own use and to use it unchanged for non- commercial research and educational purposes. Subsequent transfers of copyright cannot revoke this permission. All other uses of the document are conditional upon the consent of the copyright owner. The publisher has taken technical and administrative measures to assure authenticity, security and accessibility. According to intellectual property law, the author has the right to be mentioned when his/her work is accessed as described above and to be protected against infringement. For additional information about Linköping University Electronic Press and its procedures for publication and for assurance of document integrity, please refer to its www home page: http://www.ep.liu.se/. Linköping University Electronic Press Linköping, Sweden, 2015 ISBN: 978-91-7519-076-1 © Börje Svensson, 2015 [email protected] Photo at the front page: “White leghorn rooster” by Sándor Szirmai. Gift from the artist to Endre Balazs (May 22, 1962) 2 Contents Preface ................................................................................................................................. 5 Part I: The early years of the Healon project (1971-77) ............................................... 11 CHAPTER 1: Introduction .................................................................................................... 11 CHAPTER 2: The Healon project is adopted by Pharmacia ................................................ 17 CHAPTER 3: Promising start followed by unforeseen setbacks .......................................... 25 CHAPTER 4: License agreement with restrictions ............................................................... 29 CHAPTER 5: License agreement re-negotiated .................................................................. 33 CHAPTER 6: New production plant - an ill-conceived decision ........................................... 37 CHAPTER 7: My own participation in the Healon project .................................................... 43 CHAPTER 8: The Healon project evaluated ........................................................................ 45 Part II: Healon - a revolution in cataract surgery .......................................................... 51 CHAPTER 9: The discovery of the cataract surgery market ................................................ 51 CHAPTER 10: Healon’s development according to Pharmacia’s annual reports ................ 59 CHAPTER 11: Four key players at Pharmacia Ophthalmics ............................................... 66 Part III: Biomatrix – a successful manifestation of frustration ..................................... 77 CHAPTER 12: The creation of Biomatrix ............................................................................. 79 CHAPTER 13: Biomatrix’ first ten years ............................................................................... 81 CHAPTER 14: Biomatrix’ Swedish subsidiary ...................................................................... 95 CHAPTER 15: Biomatrix 1992-2000 – fast growth and big ambitions ............................... 101 CHAPTER 16: In the wake of success: Three unforeseen legal disputes ......................... 111 CHAPTER 17: What became of Synvisc? .......................................................................... 115 Part IV: Xalatan – the spin-off that became a blockbuster .......................................... 117 CHAPTER 18: The project no one wanted ......................................................................... 117 CHAPTER 19: The Xalatan saga from different perspectives ............................................ 121 CHAPTER 20: László Bitó – the man who pushed on despite his critics ........................... 131 Part V: Hyaluronic acid and facial aesthetics – a mere coincidence ....................... 143 CHAPTER 21: New products emerge from the quest for eternal youth ............................. 145 CHAPTER 22: The discovery of hyaluronic acid’s potential within the beauty industry ..... 149 CHAPTER 23: The origin of Restylane and Juvéderm ...................................................... 153 CHAPTER 24: A pioneer in the early development of Hylaform and Restylane ................ 167 CHAPTER 25: Spin-offs generate yet more spin-offs ........................................................ 173 CHAPTER 26: What became of Hylaform? ........................................................................ 177 3 Part VI: Some final thoughts .......................................................................................... 179 CHAPTER 27: Management of conflict .............................................................................. 181 CHAPTER 28: Factors for success .................................................................................... 189 Appendix A: The origins of the book and the facts on which it is based ............................ 209 Appendix B: References ..................................................................................................... 211 Appendix C: History timeline of the Magic Molecule .......................................................... 215 Appendix D: Acknowledgements ........................................................................................ 219 Appendix E: About the author………………………………………...................................... 221 4 Preface Millions of people all over the world are granted better vision thanks to a seemingly magic molecule. The molecule makes it possible to remove the eye’s lens and replace it with an artificial one. Cataracts are the cause of most lens replacements. The disease clouds the lens which in turn blurs vision. Until the early 1980’s, lens transplants were a very complicated affair, so much so that many eye surgeons avoided the procedure altogether. The revolutionary events that have taken place since, now allow surgeons to perform a lens transplant in less than 15 minutes, the results of which are successful nearly every single time. This medical breakthrough was made possible by the magic molecule described in this book. The same molecule has also helped to ease ailing knees affected by arthritis. Despite the controversial nature of the molecule’s use in treating arthritis, the fact remains that many of the millions of people treated yearly report significant relief as a result. Furthermore, the molecule’s use in treating joints is not limited to those of humans, but also includes horses. Then working as product manager for the Swedish pharmaceutical company Pharmacia, I was personally involved in introducing Healonid® Vet., a product based on the magic molecule, into the French equestrian market some forty years ago. As if eyes, knees and horses were not enough, the magic molecule has even revolutionized the global beauty industry during the past twenty years. Commonly used as the main ingredient in dermal fillers, the molecule has enabled many of the most successful wrinkle reducing products developed by world leading companies. The magic molecule I speak of is a sugar molecule called hyaluronic acid. The modern term for the molecule is hyaluronan, often shortened HA. For the purposes of this book, the term hyaluronic acid will be used, since this is still the term most frequently used. Hyaluronic acid is found in a number of areas within the human body. In the human skin, hyaluronic acid works as a moisturizing and filling agent. In the human joint it acts as a lubricant and shock absorber. It is also found in the eye and the umbilical cord. Hyaluronic acid is also found in sources outside the human body. The hyaluronic acid described in this book originates from rooster combs or synthetically, through a process of bacterial fermentation. Hyaluronic acid was discovered in 1934 by Karl Meyer and John Palmer, researchers at Columbia University. A Hungarian researcher by the name of Endre Balazs was the first to develop hyaluronic acid for commercial use. In 1943, Balazs received a patent for a method using fluid from knee joints of cows to be used as an egg white substitute in baking. The product itself was not very successful, but Balazs was inspired to search 5 for other commercial uses for hyaluronic acid. In particular, he was eager to discover medical benefits of its use. Endre Balazs is still driven by this eagerness, at 95 years of age. Throughout his career, he has successfully transformed research into practical benefit to an extent that most researchers only dream of. Part I: The first six years (1971-77) – if not for the placebo effect If it is possible to call a molecule magic, hyaluronic acid is certainly deserving. That which has been accomplished as a result of its discovery has been truly astounding. Hyaluronic acid’s commercial journey within medicine began some 43 years ago, marked by Endre Balazs crossing paths with Torvard Laurent, professor at Uppsala University, and Harry Hint, Chief Scientific Officer at Pharmacia, a pharmaceutical company located in Uppsala, Sweden. Both Laurent and Hint knew Balazs from his time as guest researcher at Karolinska Institutet (KI) in Stockholm in the late 1940’s.
Load more

Recommended publications
  • The Biotech Heart of Sweden Second in a Series Covering the “Hot Spots” of Biotech Research and Business Around the Globe
    The Biotech Heart of Sweden Second in a series covering the “hot spots” of biotech research and business around the globe. BY FELICIA M. WILLIS Läby Harbo Skyttorp Åkerlänna Alunda Björklinge Vattholma Jumkil Lövstalöt Storvreta Bälinge Rasbo ICELAND Norwegian Gamla Uppsala Sea Länna Järlåsa Almunge SWEDEN FINLAND Vänge Gulf UPPSALA Gunsta North NORWAY of Atlantic Bothnia Ocean Sävja • UPPSALA Gottsunda • STOCKHOLM RUSSIA Bergsbrunna ESTONIA North Sunnersta Sea LATVIA DENMARK Baltic HusbyLång IRELAND Sea LITHUANIA Alsike U. K. NETH. BYELARUS Örsundsbro Knivsta Skeppture GERMANY POLAND English Channel BELGIUM Skokloster UKRAINE LUX. CZECH SLOVAKIA MOLDOVA FRANCE AUSTRIA SWITZERLAND HUNGARY Bay of Biscay SLOVENIA ROMANIA CROATIA Black BOSNIA Sea SERBIA BULGARIA weden is the fourth-largest biotech nation ANDORRA MONTENEGRO PORTUGAL ITALY MACEDONIA in Europe and accounts for 1–4% of articles in scientific SPAIN Adriatic Tyrrhenian ALBANIA Sea TURKEY journals. Uppsala, nicknamed “the world’s most biotech- Aegean S GREECE Ionian intense city”, is 50 miles northwest of Stockholm. Uppsala started Mediterranean Sea Sea in biotech in the 1940s with a lone pharmaceutical company, known amounts CYPRUS then as Pharmacia. Since that time, the company has made of money in research many changes, including merging with Upjohn, forming a biotech- and product development. This nology products joint venture with Amersham, and being acquired trend continued during the 1970s, when the pas- later by Pfizer. Although many other companies are in Sweden sion that Swedish companies felt about R&D became known now, Pharmacia laid the groundwork for the upsurge of biotech. internationally. In the early 1980s, the Swedish endeavor began to According to information from Uppsala BIO, 8% of Uppsala’s work- increase rapidly, and it grew at an average annual rate of about 20% force is employed in biotech.
    [Show full text]
  • Lifestyle Features Monday, August 24, 2020
    13 Lifestyle Features Monday, August 24, 2020 View of the pool and bungalow area and Sunset strip from Chateau Marmont View of Chateau Marmont on Sunset Strip, in West Hollywood, California. — AFP photos penthouse. or nearly a century Chateau Marmont has been just a decade ago. At Chateau Marmont, shielded-off an adopted home and playground for private quarters will serve an “essentially nomadic” FHollywood’s elite, discreetly hosting sophisticat- wealthy and creative elite tired of traditional luxury ed Golden Age icons and raucous Brat Pack celebri- hotels, Balazs said. But Balazs insists media reports ties. Etched into Tinseltown folklore, it is where James that “the Chateau” is set to ape “exclusionary clubs” Dean crashed director Nicholas Ray’s bungalow to like White’s in London, are wide of the mark. bag the lead in “Rebel Without a Cause,” Jean Harlow Those reports triggered a backlash in Los Angeles and Clark Gable allegedly conducted a torrid affair, among stargazers fearful they will no longer be able and comedy legend John Belushi died of a tragic drug to dine across from their favorite celebrities. “There overdose. More recently, the imposing Gothic hotel will always be a public component” to Chateau perched above the famous Sunset Strip has become a Marmont, Balazs told AFP, including “probably the hub for swanky showbiz parties, from Leonardo restaurant... and then maybe some public aspect to View of the entrance of the lobby from the restaurant DiCaprio’s 21st birthday bash to Beyonce and Jay-Z’s the rooms as well.” “Something that’s become as, if View of the Chateau Marmont Bungalow living room.
    [Show full text]
  • 50 Years of Sephadex Gel Learning from a Scandinavian Saga
    FOCUS ON... TECHNOLOGY 50 Years of Sephadex Gel Learning from a Scandinavian Saga by Eric Grund and Jan-Christer Janson t has been fifty years since the separate biomolecules. He was first Sephadex paper was awarded the Nobel Prize in 1948, “for published (1). Readers of BioProcess his research on electrophoresis and I International work in a field that adsorption analysis, especially for his was fundamentally affected by what discoveries concerning the complex happened after that paper was nature of the serum proteins.” He published in 1959. So this anniversary coined the names alpha-, beta- and is certainly worthy of a party and a gamma-globulins (3). Six decades few speeches. But there are lessons to later, following enormous technical be learned, too. Let’s look at threads refinements and combining connecting events before and after the knowledge of the structure of DNA discovery of gel filtration with the discovery of specialized chromatography and introduction of bacterial enzymes, electrophoresis was the Sephadex product. used to perform decisive steps in the sequencing of the human genome (4). INTERD I SC I PL I NARY RESEARCH When someone with expertise in one WHEN PURE SC I ENCE field joins a team from another field, COLLABORATES wi TH INDUSTRY great leaps of mind can occur, and In Uppsala, Svedberg was a keen longstanding problems can be solved GE HEALTHCARE (WWW.GEHEALTHCARE.COM) advocate of applying scientific with ease. Science has seen numerous discoveries to make useful products. examples of this phenomenon, There, Svedberg’s eyes were opened Indeed, he thought it was almost particularly the field of bioseparations.
    [Show full text]
  • In the Spirit
    GLOBAL GOING LUXE REACH THE BELLEVUE COLLECTION AS PROFITS AT PLOTS A $1.2 BILLION ERMENEGILDO ZEGNA RISE EXPANSION TO RAISE THE 13 PERCENT, THE BRAND LUXURY QUOTIENT IN SEATTLE. PLANS MORE RETAIL EXPANSION. PAGE 2 PAGE 12 BANGLADESH TRAGEDY Retailers, Groups Vow Compensation By MAYU SAINI WHO IS GOING TO PAY and how much? That is among the questions being asked as the death toll from the collapse of the apparel factory building in Savar, near Dhaka, Bangladesh, rose to 430 on Thursday, with more than 520 injured, out of which 100 amputations have been estimated. FRIDAY, MAY 3, 2013 ■ WOMEN’S WEAR DAILY ■ $3.00 The rest of the rescued workers will also need WWD new jobs, as well as immediate payments. Hundreds of workers are still missing, and eight days after the eight-story building collapsed, bodies are still being recovered from the debris. The building, Rana Plaza, housed fi ve garment fac- tories, with more than 3,000 workers in the building at the time of the collapse. The incident is being de- scribed by authorities as the worst industrial accident in the garment industry in Bangladesh and the world. “The total compensation fi gure is likely to be over $30 million in addition to the cost of emergency treat- ment,” the Clean Clothes Campaign said last week, when the death toll was known to be 300. In the But a presentation by the Bangladesh Garment Manufacturers & Exports Association earlier this week noted a vastly different number, stating that the amount needed for “compensation, rehabilitation and long-term treatment was estimated at $12 million.” The organization also noted that an amount of 125 Spirit million Bangladesh taka, or $1.6 million at current ex- change rates, had already been spent on rescue activi- The Estée Lauder brand will ties and treatment.
    [Show full text]
  • UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT of NEW YORK : in Re: : Chapter 11 : 1141 REALTY OWNER LLC, Et Al., : Case No
    18-12341-smb Doc 36 Filed 09/05/18 Entered 09/05/18 10:47:47 Main Document Pg 1 of 217 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK : In re: : Chapter 11 : 1141 REALTY OWNER LLC, et al., : Case No. 18-12341 (SMB) : : Jointly Administered Debtors. : : DECLARATION OF EDWARD R. ESCHMANN IN FURTHER SUPPORT OF DEBTORS’ MOTION FOR ENTRY OF INTERIM AND FINAL ORDERS AUTHORIZING THE DEBTORS TO OBTAIN POST-PETITION, PRIMING, SENIOR SECURED, SUPERPRIORITY FINANCING PURSUANT TO 11 U.S.C. §§ 105, 362, 364(c) AND 364(d), BANKRUPTCY RULE 4001(c) AND LOCAL BANKRUPTCY RULE 4001-2 Edward R. Eschmann, MAI, declares as follows pursuant to 28 U.S.C. § 1746: 1. I am a Director of the Valuation and Advisory Hospitality and Gaming Group of CBRE, Inc. (“CBRE”) in New York City, where I have been employed since 2000. 2. I have more than thirty-four (34) years’ experience of valuation and consulting experience throughout the United States, Puerto Rico and the Americas. I am a designated Member of the Appraisal Institute and Royal Institution of Chartered Surveyors and a Certified General Real Estate Appraiser in the states of New York and New Jersey and have held licenses in other jurisdictions including Connecticut, Vermont, Illinois, Washington, DC and Pennsylvania. I have a Bachelor of Science degree from the University of Massachusetts, Amherst. 3. Since 2006, I have specialized in the hospitality asset class and have been the director of the Tri-State Hospitality Group of CBRE in New York City covering the New York, New Jersey and Connecticut region.
    [Show full text]
  • 2007 Manhattan Hotel Market Overview Page 1 of 28
    HVS Hospitality Services : 2007 Manhattan Hotel Market Overview Page 1 of 28 Manhattan Hotel Market Overview HVS Hospitality Services, in cooperation with New York University's Preston Robert Tisch Center for Hospitality, Tourism, and Sports Management, is pleased to present the tenth annual Manhattan Hotel Market Overview. A slight uptick in Manhattan’s occupancy level in 2006 led to a record high of 85.0%. Despite a virtually stable occupancy, the Manhattan lodging market registered a 13.4% increase in RevPAR compared to 2005, continuing its impressive performance. The market’s RevPAR gain was supported by double-digit growth in average rate each month of the year, with the exception of December, causing year-end 2006 average rate to exceed the 2005 level by 13.2%. The high rates registered by the Manhattan lodging market were caused primarily by continued strong demand levels in 2006, allowing hotel operators to be more selective with lower-rated demand and increasingly boost rates, thereby accommodating greater numbers of higher-rated travelers. We note that the market’s overall occupancy level of 85.0% in 2006 highlights the underlying strength of the Manhattan market, which continued to operate at near-maximum-capacity levels. Because of a further decline in supply in 2006, the market continued to experience many sell-out nights, causing a significant amount of demand to remain unaccommodated. Given the larger-than-ever construction pipeline in Manhattan, a substantial portion of previously unaccommodated demand is expected to be accommodated in the future. Manhattan’s marketwide occupancy and average rate both achieved new record levels in 2006, and we expect the positive trend to continue in 2007.
    [Show full text]
  • The 100 Most Powerful People in New York Real Estate
    NEW YORK, THE REAL ESTATE Jerry Speyer Michael Bloomberg Stephen Ross Marc Holliday Amanda Burden Craig New- mark Lloyd Blankfein Bruce Ratner Douglas Durst Lee Bollinger Michael Alfano James Dimon David Paterson Mort Zuckerman Edward Egan Christine Quinn Arthur Zecken- dorf Miki Naftali Sheldon Solow Josef Ackermann Daniel Boyle Sheldon Silver Steve Roth Danny Meyer Dolly Lenz Robert De Niro Howard Rubinstein Leonard Litwin Robert LiMandri Howard Lorber Steven Spinola Gary Barnett Bill Rudin Ben Bernanke Dar- cy Stacom Stephen Siegel Pam Liebman Donald Trump Billy Macklowe Shaun Dono- van Tino Hernandez Kent Swig James Cooper Robert Tierney Ian Schrager Lee Sand- er Hall Willkie Dottie Herman Barry Gosin David Jackson Frank Gehry Albert Behler Joseph Moinian Charles Schumer Jonathan Mechanic Larry Silverstein Adrian Benepe Charles Stevenson Jr. Michael Fascitelli Frank Bruni Avi Schick Andre Balazs Marc Jacobs Richard LeFrak Chris Ward Lloyd Goldman Bruce Mosler Robert Ivanhoe Rob Speyer Ed Ott Peter Riguardi Scott Latham Veronica Hackett Robert Futterman Bill Goss Dennis DeQuatro Norman Oder David Childs James Abadie Richard Lipsky Paul del Nunzio Thomas Friedan Jesse Masyr Tom Colicchio Nicolai Ourouso! Marvin Markus Jonathan Miller Andrew Berman Richard Brodsky Lockhart Steele David Levinson Joseph Sitt Joe Chan Melissa Cohn Steve Cuozzo Sam Chang David Yassky Michael Shvo 100The 100 Most Powerful People in New York Real Estate Bloomberg, Trump, Ratner, De Niro, the Guy Behind Craigslist! They’re All Among Our 100 Most Powerful People in New York Real Estate ower. Webster’s Dictionary defines power as booster; No. 15 Edward Egan, the Catholic archbish- Governor David Paterson (No.
    [Show full text]
  • Daylight & Architecture
    LUX E DAYLIGHT & DAYLIGHT ARCHITECTURE BY MAGAZINE V WINTER 2008 ISSUE 10 RE-NEW 10 EURO WINTER 2008 ISSUE 10 RE-NEW 10 EURO DAYLIGHT & ArCHITECTURE MAGAZine BY VELUX Cities are like living organisms. They remain alive by continually renewing themselves. E Just as the human body’s lifespan exceeds that of its individual cells, a town gener- VELUX ally outlives its individual houses defensive walls and factories. Buildings age over time. They become unusable or no longer meet increasing expectations about com- EDITORIAL fort and space. Sometimes they are simply not impressive enough for new users or functions. These circumstances make the desire for something new only too under- standable. But there are good reasons for not acceding to calls for renewal invariably and unthinkingly. RE-NEW Renovating an old building uses up to two thirds less material than an equiva- lent new building – saving the equivalent amount of energy for producing and trans- porting materials, as Thomas Lemken writes in his article for Daylight&Architecture. Many old buildings additionally possess unrivalled construction qualities – whether a “bonus” in terms of room height and width or details and decorations in the work- manship no longer found in new buildings. Often, however, these aesthetic qualities are hidden, and it takes the work of an architect to bring them to light. In his article “More space, more light” in this issue, Hubertus Adam describes how this can hap- pen. However, existing buildings in our cities and villages also represent an unparal- leled challenge. Badly insulated old buildings are among humanity’s greatest energy wasters.
    [Show full text]
  • Regional Strategies of Multinational Pharmaceutical Firms
    Alan M. Rugman/Cecilia Brain Regional Strategies of Multinational Pharmaceutical Firms Abstract Recent research on the world’s 500 largest companies has established that the majority of international business occurs within regional clusters in the three largest economic regions of North America, Europe, and Asia (the triad). This finding extends to the 18 companies in the chemicals and pharmaceuticals sector, which is the most innovative in the world. Key Results This paper examines the R&D and strategies of the world’s largest firms in the pharmaceuticals sector and finds a high degree of intra-regional sales. R&D and sales are more concentrated within North America and Europe than in Asia. In addition, the relative size of the U.S. market, compared to other parts of the triad, creates imbalances with respect to R&D, sales and international strategy. Authors Alan Rugman, L. Leslie Waters Chair in International Business, Kelley School of Business, Indiana University, Bloomington, IN 47401-1701 USA Cecilia Brain, principal and CEO of Braintrust, a Toronto-based consulting organization. Abbreviated Heading: Regional Strategies in Chemicals Introduction A new research stream has demonstrated that the vast majority of international business activity is conducted on a regional basis, rather than globally. By regional is meant the large “triad” markets of the European Union (E.U.), the United States (or, more broadly, NAFTA), and Japan (or, more broadly, all of Asia). This research is illustrated in Rugman (2000) (2003), Rugman and Brain (2003), and Rugman and Verbeke (2004). Of the world’s 500 largest multinational enterprises (MNEs), the sector which is consistently one of the most innovative is chemicals and pharmaceuticals.
    [Show full text]
  • Print Untitled (24 Pages)
    SYDELL GROUP LTD. Andrew Zobler Sydell Group 2006-Present Founder and ChiefExecutive Officer The Sydell Group is a New York based owner and developer of lifestyle oriented hotels. Sydell currently controls two ventures in partnership with the Yucaipa companies. The first venture targets urban lifestyle oriented hotel properties with a strategy to acquire and develop hotels with individualized brand, design and management. The mandate of the second venture is to develop and operate premium youth hostels in major U.S. cities. Existing Projects: • NoMad Hotel, New York o Converted a 133,000 SF landmark office building into a 168-room luxury boutique hotel. The NoMad restaurant is operated by James Beard-Best Chef in America, Daniel Humm, and recently earned three-stars from the New York Times. • Ace Hotel, New York o This 180,000 SF building, which is named on the historic register, was converted to a 275-roorri hotel and was recently touted as "Best Boutique Design Hotel" by Interior Design magazine. • Ace Hotel, Palm Springs o 180-room renovation which is perhaps most well-known for its installation of Stan Bitter's work, which helped to transform the tired former Howard Johnson into a building with striking, original handcrafted detail. • The Saguaro, Old Town Scottsdale o Renovated and re-branded the former Hotel Theodore into a 195-room lifestyle hotel operated by Joie de Vivre with food & beverage offerings by James Beard award winner Jose Garces. • The Saguaro, Palm Springs o Renovated and re-branded a former Holiday Inn into a 245-room lifestyle hotel operated by Joie de Vivre with food & beverage offerings by James Beard award winner Jose Garces.
    [Show full text]
  • Case No COMP/M.1835 - MONSANTO / PHARMACIA & UPJOHN
    EN Case No COMP/M.1835 - MONSANTO / PHARMACIA & UPJOHN Only the English text is available and authentic. REGULATION (EEC) No 4064/89 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 30/03/2000 Also available in the CELEX database Document No 300M1835 Office for Official Publications of the European Communities L-2985 Luxembourg COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 30.03.2000 PUBLIC VERSION In the published version of this decision, some information has been omitted pursuant to Article 17(2) of Council Regulation (EEC) No 4064/89 concerning non-disclosure of business secrets and other confidential information. The omissions are shown thus […]. Where possible the information MERGER PROCEDURE omitted has been replaced by ranges of figures or a 6(1)b DECISION general description. To the notifying parties Dear Sirs, Subject: Case No IV/M. 1835 Monsanto/Pharmacia & Upjohn Your notification of 16.2.2000 pursuant to Article 4 of Council Regulation No 4064/891 1. On 16.2.2000, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EEC) No 4064/89 (“the Merger Regulation”) by which Monsanto Company (“Monsanto”) and Pharmacia Upjohn, Inc. (P&U) enter into a full merger within the meaning of Article 3(1)(a) of the Council Regulation. 2. In the course of the proceedings, the parties submitted undertakings designed to eliminate competition concerns identified by the Commission, in accordance with Article 6(2) of the Merger Regulation. In the light of these modifications, the Commission has concluded that the notified operation falls within the scope of the Merger Regulation as amended and does not raise serious doubts as to its compatibility with the common market and with the functioning of the EEA Agreement.
    [Show full text]
  • Open PDF ... AIA-New-York-Chapter
    7/12/2014 AIA New York Chapter : Calendar Search... » The Center for Architecture 536 LaGuardia Place Boat Tours Calendar Visit Education Exhibitions Support Public Programs Watch & Listen Program Partners Space Rental NY, NY 10012 (212) 683-0023 [email protected] Gallery Hours Mon-Fri: 9am to 8pm Sat: 11am to 5pm Office Hours Mon 07.14.2014 Mon-Fri: 9am to 5pm Keep in touch AIA CES 2.5 LU Subscribe now When: 6:30 PM - 9:00 PM MONDAY, JULY 14 Where: At The Center You RSVPed YES on: [Jul 12, 2014 10.31 am] ADD A GUEST export vCalendar The AIANY Global Dialogues Committee has dedicated this year to “(dis)Covered Identities.” The theme aims to explore ways by which cultures, cities, and voices define or refine their identities through a global exchange of ideas and conversations covering multiple topics, perspectives and trends of our time. "Viral Voices" will specifically explore the impact of social media, technology, and device culture on our design process and the way we practice. How do we shape a global conversation? Greg Lindsay, contributing writer for Fast Company and co-author of Aerotropolis with David Basulto and David Assael of ArchDaily will come together for a lecture discussing the relationships between social media and the profession. Following the lecture, Robyn Peterson from Mashable, Jaime Derringer from Design Milk, Diana Jou from the The Wall Street Journal, Rafi Segal from MIT Architecture / Architect/Blogger, Mark Collins from The Morpholio Project | The GSAPP CloudLab, and Kyle May from Clog will join the speakers for a panel discussion.
    [Show full text]